Professor John Dillon
Clinical Professor (Teaching and Research)
Molecular and Clinical Medicine, School of Medicine
+44 (0)1382 383017
Testing and treating patients for hepatitis c when they receive methadone treatment could be the key to meeting the global target of eliminating the disease by 2030, University of Dundee research has shown.
Impact case study
The ‘intelligent Liver Function Test’ has improved patient outcomes and quality of care.
A University of Dundee academic is to head up the clinical trial of a wearable device that aims to reduce the growing number of fatal opioid overdoses in Scotland.
Professor Dillon's research and clinical practice focuses on hepatology or liver disease. His research is broad but covers all aspects of Viral hepatitis, alcohol-related liver disease and early detection of liver disease, both in the UK and internationally. Additionally he works with people who inject drugs to reduce drug related deaths.
I am available for media commentary on my research.
Contact Corporate Communications for media enquiries.
Areas of Expertise
- Hepatitis C
- Liver disease